跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cefroxime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Cefroxime
Approved
STANDARD
Cefroxime
NCPC Hebei Pharmaceutical Company Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4c82dadbc2b6ac10
Company
NCPC Hebei Pharmaceutical Company Limited
Type
Standard
Approval Details
Approval Id
4c82dadbc2b6ac10
Drug Approval Philippines Name
Cefroxime
Product Name
Cefroxime
Registration Number
DRP-6570-02
Brand Name
Cefroxime
Generic Name
Cefuroxime (as Sodium)
Dosage Form
Powder for Injection (I.M./I.V.)
Dosage Strength
750 mg
Manufacturer
NCPC Hebei Pharmaceutical Company Limited
Importer
Aglobal Care, Inc
Distributor
Eliset Pharmaceutical, Inc.
Issuance Date
24 January 2024
Expiry Date
10 March 2029
Pharmacologic Category
Antibacterial
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4c82dadbc2b6ac10
Type
Standard
Back to Philippines FDA Approvals